Trial Profile
A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Mental retardation; Pervasive child development disorders
- Focus Therapeutic Use
- 03 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2006 New trial record.